Additions and Deletions to the Drug Product List

Home , Methylene blue

Prescription and Over-the-Counter Drug Product List 40TH EDITION Cumulative Supplement Number 06 : June 2020 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ACETAMINOPHEN; BUTALBITAL; CAFFEINE CAPSULE;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> AA TARO PHARM INDS LTD 300MG;50MG;40MG A 213046 001 Jul 01, 2020 Jun NEWA

ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >D> AA GRANULES PHARMS 325MG;5MG A 211729 001 Jan 03, 2020 Jun DISC >A> @ 325MG;5MG A 211729 001 Jan 03, 2020 Jun DISC >D> AA 325MG;7.5MG A 211729 002 Jan 03, 2020 Jun DISC >A> @ 325MG;7.5MG A 211729 002 Jan 03, 2020 Jun DISC >D> AA 325MG;10MG A 211729 003 Jan 03, 2020 Jun DISC >A> @ 325MG;10MG A 211729 003 Jan 03, 2020 Jun DISC

ACYCLOVIR SODIUM INJECTABLE;INJECTION ACYCLOVIR SODIUM >A> AP EXELA PHARMA SCS LLC EQ 50MG BASE/ML A 207919 001 Jun 17, 2020 Jun NEWA

ADAPALENE GEL;TOPICAL ADAPALENE >A> AB ALEOR DERMACEUTICALS 0.3% A 213508 001 Jun 18, 2020 Jun NEWA

>D> AIR POLYMER-TYPE A >D> FOAM;INTRAUTERINE >D> EXEM FOAM KIT >D> +! GISKIT 10ML N 212279 001 Nov 07, 2019 Jun DISC >A> + @ 10ML N 212279 001 Nov 07, 2019 Jun DISC

ALBENDAZOLE TABLET;ORAL ALBENDAZOLE >A> AB LUPIN LTD 200MG A 211636 001 Jun 10, 2020 Jun NEWA

ALPRAZOLAM TABLET;ORAL ALPRAZOLAM >D> AB OXFORD PHARMS 0.25MG A 078491 001 Sep 25, 2008 Jun DISC >A> @ 0.25MG A 078491 001 Sep 25, 2008 Jun DISC >D> AB 0.5MG A 078491 002 Sep 25, 2008 Jun DISC >A> @ 0.5MG A 078491 002 Sep 25, 2008 Jun DISC >D> AB 1MG A 078491 003 Sep 25, 2008 Jun DISC >A> @ 1MG A 078491 003 Sep 25, 2008 Jun DISC >D> AB 2MG A 078491 004 Dec 12, 2008 Jun DISC >A> @ 2MG A 078491 004 Dec 12, 2008 Jun DISC

ALVIMOPAN CAPSULE;ORAL >D> ALVIMOPAN >D> AB WATSON LABS TEVA 12MG A 208295 001 Dec 19, 2019 Jun DISC >A> @ 12MG A 208295 001 Dec 19, 2019 Jun DISC ENTEREG >D> AB +! CUBIST PHARMS 12MG N 021775 001 May 20, 2008 Jun CTEC >A> +! 12MG N 021775 001 May 20, 2008 Jun CTEC

AMANTADINE HYDROCHLORIDE CAPSULE;ORAL AMANTADINE HYDROCHLORIDE >D> AB BIONPHARMA INC 100MG A 078720 001 May 29, 2008 Jun CHRS >A> AB ! 100MG A 078720 001 May 29, 2008 Jun CHRS >D> AB ! SANDOZ 100MG A 071293 001 Feb 18, 1987 Jun CHRS >A> AB 100MG A 071293 001 Feb 18, 1987 Jun CHRS

Page 1 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

AMLODIPINE BESYLATE TABLET;ORAL NORVASC >D> AB + PFIZER EQ 2.5MG BASE N 019787 001 Jul 31, 1992 Jun CAHN >D> AB + EQ 5MG BASE N 019787 002 Jul 31, 1992 Jun CAHN >D> AB +! EQ 10MG BASE N 019787 003 Jul 31, 1992 Jun CAHN >A> AB + UPJOHN EQ 2.5MG BASE N 019787 001 Jul 31, 1992 Jun CAHN >A> AB + EQ 5MG BASE N 019787 002 Jul 31, 1992 Jun CAHN >A> AB +! EQ 10MG BASE N 019787 003 Jul 31, 1992 Jun CAHN

AMLODIPINE BESYLATE; VALSARTAN TABLET;ORAL AMLODIPINE BESYLATE AND VALSARTAN >D> AB PAR PHARM INC EQ 5MG BASE;160MG A 090011 001 Mar 28, 2013 Jun DISC >A> @ EQ 5MG BASE;160MG A 090011 001 Mar 28, 2013 Jun DISC >D> AB EQ 5MG BASE;320MG A 090011 003 Mar 28, 2013 Jun DISC >A> @ EQ 5MG BASE;320MG A 090011 003 Mar 28, 2013 Jun DISC >D> AB EQ 10MG BASE;160MG A 090011 002 Mar 28, 2013 Jun DISC >A> @ EQ 10MG BASE;160MG A 090011 002 Mar 28, 2013 Jun DISC >D> AB EQ 10MG BASE;320MG A 090011 004 Mar 28, 2013 Jun DISC >A> @ EQ 10MG BASE;320MG A 090011 004 Mar 28, 2013 Jun DISC

AMOXICILLIN TABLET, CHEWABLE;ORAL AMOXICILLIN >A> AB HIKMA 125MG A 205274 001 Jun 25, 2020 Jun NEWA >A> AB 250MG A 205274 002 Jun 25, 2020 Jun NEWA >D> TEVA 125MG A 064013 002 Sep 11, 1995 Jun CTEC >A> AB 125MG A 064013 002 Sep 11, 1995 Jun CTEC >D> ! 250MG A 064013 001 Dec 22, 1992 Jun CTEC >A> AB ! 250MG A 064013 001 Dec 22, 1992 Jun CTEC

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE >A> AB MYLAN 1.25MG;1.25MG;1.25MG;1.25MG A 211876 001 Jun 24, 2020 Jun NEWA >A> AB 2.5MG;2.5MG;2.5MG;2.5MG A 211876 002 Jun 24, 2020 Jun NEWA >A> AB 3.75MG;3.75MG;3.75MG;3.75MG A 211876 003 Jun 24, 2020 Jun NEWA >A> AB 5MG;5MG;5MG;5MG A 211876 004 Jun 24, 2020 Jun NEWA >A> AB 6.25MG;6.25MG;6.25MG;6.25MG A 211876 005 Jun 24, 2020 Jun NEWA >A> AB 7.5MG;7.5MG;7.5MG;7.5MG A 211876 006 Jun 24, 2020 Jun NEWA

APIXABAN TABLET;ORAL APIXABAN >D> AB MICRO LABS 2.5MG A 210013 001 Dec 23, 2019 Jun DISC >A> @ 2.5MG A 210013 001 Dec 23, 2019 Jun DISC >D> AB 5MG A 210013 002 Dec 23, 2019 Jun DISC >A> @ 5MG A 210013 002 Dec 23, 2019 Jun DISC

ASPIRIN; OXYCODONE HYDROCHLORIDE TABLET;ORAL OXYCODONE AND ASPIRIN >D> AA ACTAVIS LABS FL INC 325MG;4.8355MG A 090084 001 Mar 22, 2011 Jun DISC >A> @ 325MG;4.8355MG A 090084 001 Mar 22, 2011 Jun DISC

ATAZANAVIR SULFATE CAPSULE;ORAL ATAZANAVIR SULFATE >A> AB ZYDUS PHARMS EQ 150MG BASE A 210575 001 Jun 04, 2020 Jun NEWA >A> AB EQ 200MG BASE A 210575 002 Jun 04, 2020 Jun NEWA >A> AB EQ 300MG BASE A 210575 003 Jun 04, 2020 Jun NEWA

ATENOLOL TABLET;ORAL ATENOLOL >A> AB HLTHCARE 25MG A 073026 002 May 01, 1992 Jun CMS1 >A> AB 50MG A 073026 003 Sep 17, 1991 Jun CMS1

Page 2 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ATORVASTATIN CALCIUM TABLET;ORAL ATORVASTATIN CALCIUM >A> AB PERRIGO R AND D EQ 10MG BASE A 208478 001 Jun 23, 2020 Jun NEWA >A> AB EQ 20MG BASE A 208478 002 Jun 23, 2020 Jun NEWA LIPITOR >D> AB + PFIZER EQ 10MG BASE N 020702 001 Dec 17, 1996 Jun CAHN >D> AB + EQ 20MG BASE N 020702 002 Dec 17, 1996 Jun CAHN >D> AB + EQ 40MG BASE N 020702 003 Dec 17, 1996 Jun CAHN >D> AB +! EQ 80MG BASE N 020702 004 Apr 07, 2000 Jun CAHN >A> AB + UPJOHN EQ 10MG BASE N 020702 001 Dec 17, 1996 Jun CAHN >A> AB + EQ 20MG BASE N 020702 002 Dec 17, 1996 Jun CAHN >A> AB + EQ 40MG BASE N 020702 003 Dec 17, 1996 Jun CAHN >A> AB +! EQ 80MG BASE N 020702 004 Apr 07, 2000 Jun CAHN

AZACITIDINE POWDER;INTRAVENOUS, SUBCUTANEOUS AZACITIDINE >A> AP EUROHLTH INTL SARL 100MG/VIAL A 209337 001 Jun 08, 2020 Jun NEWA

AZITHROMYCIN TABLET;ORAL AZITHROMYCIN >D> AB YUNG SHIN PHARM EQ 600MG BASE A 211068 001 May 08, 2020 Jun DISC >A> @ EQ 600MG BASE A 211068 001 May 08, 2020 Jun DISC

BARIUM SULFATE SUSPENSION;ORAL >A> ENTERO VU 24% >A> +! BRACCO 24% (144GM/600ML) N 208143 008 May 29, 2020 Jun NEWA

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE >D> AB APOTEX 5MG;6.25MG A 078794 001 Aug 21, 2014 Jun DISC >A> @ 5MG;6.25MG A 078794 001 Aug 21, 2014 Jun DISC >D> AB 10MG;12.5MG A 078794 002 Aug 21, 2014 Jun DISC >A> @ 10MG;12.5MG A 078794 002 Aug 21, 2014 Jun DISC >D> AB 20MG;12.5MG A 078794 003 Aug 21, 2014 Jun DISC >A> @ 20MG;12.5MG A 078794 003 Aug 21, 2014 Jun DISC >D> AB 20MG;25MG A 078794 004 Aug 21, 2014 Jun DISC >A> @ 20MG;25MG A 078794 004 Aug 21, 2014 Jun DISC

BETAMETHASONE DIPROPIONATE SPRAY;TOPICAL >A> BETAMETHASONE DIPROPIONATE >A> AB TARO PHARMS EQ 0.05% BASE/SPRAY A 211722 001 Jun 17, 2020 Jun NFTG >A> @ EQ 0.05% BASE/SPRAY A 211722 001 Jun 17, 2020 Jun DISC SERNIVO >D> +! ENCORE DERMAT EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Jun CFTG >A> AB +! EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Jun CFTG >A> +! EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Jun CTEC

BEXAROTENE CAPSULE;ORAL BEXAROTENE >A> AB HIKMA 75MG A 203663 001 Jun 16, 2020 Jun NEWA

BOSENTAN TABLET;ORAL BOSENTAN >D> AB CIPLA 62.5MG A 210342 001 Jan 03, 2020 Jun DISC >A> @ 62.5MG A 210342 001 Jan 03, 2020 Jun DISC >D> AB 125MG A 210342 002 Jan 03, 2020 Jun DISC >A> @ 125MG A 210342 002 Jan 03, 2020 Jun DISC

Page 3 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

BRIMONIDINE TARTRATE SOLUTION/DROPS;OPHTHALMIC QOLIANA >D> AT SANDOZ INC 0.15% N 021764 001 May 22, 2006 Jun CRLD >A> AT + 0.15% N 021764 001 May 22, 2006 Jun CRLD >A> AT +! 0.15% N 021764 001 May 22, 2006 Jun CHRS

BROMOCRIPTINE MESYLATE TABLET;ORAL BROMOCRIPTINE MESYLATE >D> AB MYLAN EQ 2.5MG BASE A 076962 001 Sep 24, 2004 Jun DISC >A> @ EQ 2.5MG BASE A 076962 001 Sep 24, 2004 Jun DISC

BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP;ORAL BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE >A> AA WES PHARMA INC 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Jun NEWA

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE FILM;BUCCAL >D> BUNAVAIL >D> + BDSI EQ 2.1MG BASE;EQ 0.3MG BASE N 205637 001 Jun 06, 2014 Jun DISC >A> + @ EQ 2.1MG BASE;EQ 0.3MG BASE N 205637 001 Jun 06, 2014 Jun DISC >D> + EQ 4.2MG BASE;EQ 0.7MG BASE N 205637 002 Jun 06, 2014 Jun DISC >A> + @ EQ 4.2MG BASE;EQ 0.7MG BASE N 205637 002 Jun 06, 2014 Jun DISC >D> +! EQ 6.3MG BASE;EQ 1MG BASE N 205637 003 Jun 06, 2014 Jun DISC >A> + @ EQ 6.3MG BASE;EQ 1MG BASE N 205637 003 Jun 06, 2014 Jun DISC

BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL BUPROPION HYDROCHLORIDE >D> @ YICHANG HUMANWELL 100MG A 211347 001 Oct 16, 2018 Jun CMFD >A> AB1 100MG A 211347 001 Oct 16, 2018 Jun CMFD >D> @ 150MG A 211347 002 Oct 16, 2018 Jun CMFD >A> AB1 150MG A 211347 002 Oct 16, 2018 Jun CMFD >D> @ 200MG A 211347 003 Oct 16, 2018 Jun CMFD >A> AB1 200MG A 211347 003 Oct 16, 2018 Jun CMFD >A> AB3 ZHEJIANG JUTAI PHARM 150MG A 211200 002 Apr 29, 2020 Jun NEWA

BUSPIRONE HYDROCHLORIDE TABLET;ORAL BUSPIRONE HYDROCHLORIDE >A> AB AUROBINDO PHARMA LTD 7.5MG A 078246 005 Feb 21, 2020 Jun NEWA >D> AB MYLAN 7.5MG A 075467 002 Mar 28, 2001 Jun CHRS >A> AB ! 7.5MG A 075467 002 Mar 28, 2001 Jun CHRS

CELECOXIB SOLUTION;ORAL ELYXYB >D> +! DR REDDYS 25MG/ML N 212157 001 May 05, 2020 Jun CAHN >A> +! 25MG/ML N 212157 001 May 05, 2020 Jun CAHN

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE CAPSULE;ORAL LIBRAX >A> +! BAUSCH 5MG;2.5MG N 012750 001 Sep 01, 1966 Jun CAHN >D> +! VALEANT PHARMS 5MG;2.5MG N 012750 001 Sep 01, 1966 Jun CAHN

CHLORZOXAZONE TABLET;ORAL CHLORZOXAZONE >D> @ AUROLIFE PHARMA LLC 500MG A 089853 001 May 04, 1988 Jun CMFD >A> AA 500MG A 089853 001 May 04, 1988 Jun CMFD >A> AB TEVA PHARMS USA INC 375MG A 212898 001 Jun 17, 2020 Jun NEWA >A> AB 750MG A 212898 002 Jun 17, 2020 Jun NEWA

Page 4 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CHOLINE FENOFIBRATE CAPSULE, DELAYED RELEASE;ORAL FENOFIBRIC ACID >A> AB MICRO LABS EQ 45MG FENOFIBRIC ACID A 213450 001 Jun 16, 2020 Jun NEWA >A> AB EQ 135MG FENOFIBRIC ACID A 213450 002 Jun 16, 2020 Jun NEWA

CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL CLINDAMYCIN PHOSPHATE >D> AT VINTAGE PHARMS EQ 1% BASE A 203343 001 May 29, 2015 Jun DISC >A> @ EQ 1% BASE A 203343 001 May 29, 2015 Jun DISC

CLOBAZAM TABLET;ORAL CLOBAZAM >A> AB APOTEX 10MG A 209853 001 Jun 09, 2020 Jun NEWA >A> AB 20MG A 209853 002 Jun 09, 2020 Jun NEWA

CLOBETASOL PROPIONATE CREAM;TOPICAL CLOBETASOL PROPIONATE (EMOLLIENT) >A> AB2 ANI PHARMS INC 0.05% A 075733 001 Aug 22, 2001 Jun CAHN >D> AB2 INGENUS PHARMS LLC 0.05% A 075733 001 Aug 22, 2001 Jun CAHN LOTION;TOPICAL IMPEKLO >A> +! MYLAN 0.05% N 213691 001 May 19, 2020 Jun CAHN >D> +! MYLAN LABS INC 0.05% N 213691 001 May 19, 2020 Jun CAHN

CLOMIPRAMINE HYDROCHLORIDE CAPSULE;ORAL CLOMIPRAMINE HYDROCHLORIDE >A> AB MICRO LABS 25MG A 213219 001 Jun 22, 2020 Jun NEWA >A> AB 50MG A 213219 002 Jun 22, 2020 Jun NEWA >A> AB 75MG A 213219 003 Jun 22, 2020 Jun NEWA >A> AB VGYAAN 25MG A 213221 001 Jun 22, 2020 Jun NEWA >A> AB 50MG A 213221 002 Jun 22, 2020 Jun NEWA >A> AB 75MG A 213221 003 Jun 22, 2020 Jun NEWA

CLONAZEPAM TABLET;ORAL CLONAZEPAM >D> AB MYLAN 1MG A 075150 002 Oct 05, 1998 Jun DISC >A> @ 1MG A 075150 002 Oct 05, 1998 Jun DISC

CLOPIDOGREL BISULFATE TABLET;ORAL CLOPIDOGREL BISULFATE >D> AB CELLTRION EQ 75MG BASE A 202266 001 Aug 14, 2012 Jun DISC >A> @ EQ 75MG BASE A 202266 001 Aug 14, 2012 Jun DISC >D> AB EQ 300MG BASE A 202266 002 Nov 20, 2012 Jun DISC >A> @ EQ 300MG BASE A 202266 002 Nov 20, 2012 Jun DISC

CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE >A> AA PHARM ASSOC 10MG/5ML;5MG/5ML;6.25MG/5ML A 040660 001 Dec 07, 2006 Jun CAHN >D> AA VINTAGE 10MG/5ML;5MG/5ML;6.25MG/5ML A 040660 001 Dec 07, 2006 Jun CAHN PROMETH VC W/ CODEINE >D> AA ! ACTAVIS MID ATLANTIC 10MG/5ML;5MG/5ML;6.25MG/5ML A 088764 001 Oct 31, 1984 Jun CAHN >A> AA ! NOSTRUM LABS INC 10MG/5ML;5MG/5ML;6.25MG/5ML A 088764 001 Oct 31, 1984 Jun CAHN

CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE WITH CODEINE >A> @ PHARM ASSOC 10MG/5ML;6.25MG/5ML A 040650 001 Jan 31, 2006 Jun CAHN >D> @ VINTAGE 10MG/5ML;6.25MG/5ML A 040650 001 Jan 31, 2006 Jun CAHN

Page 5 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

COLESEVELAM HYDROCHLORIDE >D> BAR, CHEWABLE;ORAL >D> WELCHOL >D> +! DAIICHI SANKYO INC 3.75GM N 210895 001 Apr 03, 2019 Jun DISC >A> + @ 3.75GM N 210895 001 Apr 03, 2019 Jun DISC

CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL CYCLOBENZAPRINE HYDROCHLORIDE >D> AB ! MYLAN PHARMS INC 10MG A 073144 001 May 30, 1991 Jun CHRS >A> AB 10MG A 073144 001 May 30, 1991 Jun CHRS >D> AB RUBICON 10MG A 208170 003 May 31, 2017 Jun CHRS >A> AB ! 10MG A 208170 003 May 31, 2017 Jun CHRS

CYTARABINE INJECTABLE;INJECTION CYTARABINE >A> AP HONG KONG 20MG/ML A 206189 001 Jun 26, 2020 Jun NEWA

DANTROLENE SODIUM INJECTABLE;INJECTION REVONTO >D> AP US WORLDMEDS 20MG/VIAL A 078378 001 Jul 24, 2007 Jun CAHN >A> AP USWM 20MG/VIAL A 078378 001 Jul 24, 2007 Jun CAHN

DAPSONE GEL;TOPICAL ACZONE >D> +! ALMIRALL 7.5% N 207154 001 Feb 24, 2016 Jun CTEC >A> AB +! 7.5% N 207154 001 Feb 24, 2016 Jun CTEC

DEFERASIROX TABLET;ORAL DEFERASIROX >A> AB ALEMBIC PHARMS LTD 180MG A 211824 003 Jun 15, 2020 Jun NEWA >A> AB AMNEAL 180MG A 210727 003 Jun 15, 2020 Jun NEWA >A> AB CIPLA 180MG A 211852 003 Jun 15, 2020 Jun NEWA >A> AB MSN 180MG A 210945 003 Jun 16, 2020 Jun NEWA >A> AB PIRAMAL HLTHCARE UK 180MG A 212995 003 Jun 15, 2020 Jun NEWA >A> AB SUN PHARM 180MG A 211641 003 Jun 15, 2020 Jun NEWA >A> AB ZYDUS PHARMS 180MG A 211383 003 Jun 15, 2020 Jun NEWA

DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-28 DESOGESTREL AND ETHINYL ESTRADIOL >D> AB ACCORD HLTHCARE 0.15MG,N/A;0.02MG,0.01MG A 209170 001 Jun 05, 2017 Jun CAHN >D> @ 0.15MG;0.03MG A 207067 001 Sep 13, 2018 Jun CAHN >A> AB NAARI PTE LTD 0.15MG,N/A;0.02MG,0.01MG A 209170 001 Jun 05, 2017 Jun CAHN >A> @ 0.15MG;0.03MG A 207067 001 Sep 13, 2018 Jun CAHN

DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL DESVENLAFAXINE SUCCINATE >D> @ YICHANG HUMANWELL EQ 50MG BASE A 210014 001 Oct 01, 2018 Jun CMFD >A> AB EQ 50MG BASE A 210014 001 Oct 01, 2018 Jun CMFD >D> @ EQ 100MG BASE A 210014 002 Oct 01, 2018 Jun CMFD >A> AB EQ 100MG BASE A 210014 002 Oct 01, 2018 Jun CMFD

DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE;INJECTION DEXAMETHASONE SODIUM PHOSPHATE >A> AP AUROBINDO PHARMA LTD EQ 10MG PHOSPHATE/ML A 210966 001 Jun 05, 2020 Jun NEWA

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION >D> DEXMEDETOMIDINE >D> AP JIANGSU HENGRUI MED EQ 200MCG BASE/2ML (EQ 100MCG A 209065 001 Sep 19, 2017 Jun CTNA BASE/ML) DEXMEDETOMIDINE HYDROCHLORIDE >A> AP JIANGSU HENGRUI MED EQ 80MCG BASE/20ML (EQ 4MCG A 209065 002 Jun 12, 2020 Jun NEWA BASE/ML)

Page 6 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION >A> DEXMEDETOMIDINE HYDROCHLORIDE >A> AP EQ 200MCG BASE/2ML (EQ 100MCG A 209065 001 Sep 19, 2017 Jun CTNA BASE/ML) >A> AP EQ 200MCG BASE/50ML (EQ 4MCG A 209065 003 Jun 12, 2020 Jun NEWA BASE/ML) >A> AP EQ 400MCG BASE/100ML (EQ 4MCG A 209065 004 Jun 12, 2020 Jun NEWA BASE/ML) PRECEDEX >A> +! HOSPIRA EQ 1MG BASE/250ML (EQ 4MCG N 021038 005 Jan 31, 2020 Jun NEWA BASE/ML)

DEXTROSE; SODIUM CHLORIDE INJECTABLE;INJECTION DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER >D> AP FRESENIUS KABI USA 2.5GM/100ML;450MG/100ML A 211190 001 Dec 20, 2019 Jun DISC >A> @ 2.5GM/100ML;450MG/100ML A 211190 001 Dec 20, 2019 Jun DISC

DICLOFENAC POTASSIUM CAPSULE;ORAL DICLOFENAC POTASSIUM >D> AB STRIDES PHARMA 25MG A 210078 001 Dec 03, 2019 Jun DISC >A> @ 25MG A 210078 001 Dec 03, 2019 Jun DISC

DIDANOSINE CAPSULE, DELAYED REL PELLETS;ORAL DIDANOSINE >D> AB AUROBINDO PHARMA 125MG A 090094 001 Sep 24, 2008 Jun CTEC >A> 125MG A 090094 001 Sep 24, 2008 Jun CTEC >D> AB 200MG A 090094 002 Sep 24, 2008 Jun CTEC >A> 200MG A 090094 002 Sep 24, 2008 Jun CTEC >D> AB 250MG A 090094 003 Sep 24, 2008 Jun CTEC >A> 250MG A 090094 003 Sep 24, 2008 Jun CTEC >D> AB 400MG A 090094 004 Sep 24, 2008 Jun CTEC >A> ! 400MG A 090094 004 Sep 24, 2008 Jun CHRS >A> 400MG A 090094 004 Sep 24, 2008 Jun CTEC >D> VIDEX EC >D> AB + BRISTOL MYERS SQUIBB 125MG N 021183 001 Oct 31, 2000 Jun DISC >A> + @ 125MG N 021183 001 Oct 31, 2000 Jun DISC >D> AB + 200MG N 021183 002 Oct 31, 2000 Jun DISC >A> + @ 200MG N 021183 002 Oct 31, 2000 Jun DISC >D> AB + 250MG N 021183 003 Oct 31, 2000 Jun DISC >A> + @ 250MG N 021183 003 Oct 31, 2000 Jun DISC >D> AB +! 400MG N 021183 004 Oct 31, 2000 Jun DISC >A> + @ 400MG N 021183 004 Oct 31, 2000 Jun DISC FOR SOLUTION;ORAL >D> VIDEX >D> +! BRISTOL-MYERS SQUIBB 10MG/ML N 020156 001 Oct 09, 1991 Jun DISC >A> + @ 10MG/ML N 020156 001 Oct 09, 1991 Jun DISC

DOFETILIDE CAPSULE;ORAL DOFETILIDE >A> AB ACCORD HLTHCARE 0.125MG A 213338 001 Jun 19, 2020 Jun NEWA >A> AB 0.25MG A 213338 002 Jun 19, 2020 Jun NEWA >A> AB 0.5MG A 213338 003 Jun 19, 2020 Jun NEWA

DOLUTEGRAVIR SODIUM >A> TABLET, FOR SUSPENSION;ORAL >A> TIVICAY PD >A> +! VIIV HLTHCARE EQ 5MG BASE N 213983 001 Jun 12, 2020 Jun NEWA

DOXAZOSIN MESYLATE TABLET, EXTENDED RELEASE;ORAL CARDURA XL >D> + PFIZER EQ 4MG BASE N 021269 001 Feb 22, 2005 Jun CAHN >D> +! EQ 8MG BASE N 021269 002 Feb 22, 2005 Jun CAHN >A> + UPJOHN EQ 4MG BASE N 021269 001 Feb 22, 2005 Jun CAHN >A> +! EQ 8MG BASE N 021269 002 Feb 22, 2005 Jun CAHN

Page 7 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DOXAZOSIN MESYLATE TABLET;ORAL CARDURA >D> AB +! PFIZER EQ 1MG BASE N 019668 001 Nov 02, 1990 Jun CAHN >D> AB + EQ 2MG BASE N 019668 002 Nov 02, 1990 Jun CAHN >D> AB + EQ 4MG BASE N 019668 003 Nov 02, 1990 Jun CAHN >D> AB + EQ 8MG BASE N 019668 004 Nov 02, 1990 Jun CAHN >A> AB +! UPJOHN EQ 1MG BASE N 019668 001 Nov 02, 1990 Jun CAHN >A> AB + EQ 2MG BASE N 019668 002 Nov 02, 1990 Jun CAHN >A> AB + EQ 4MG BASE N 019668 003 Nov 02, 1990 Jun CAHN >A> AB + EQ 8MG BASE N 019668 004 Nov 02, 1990 Jun CAHN

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL DOXEPIN HYDROCHLORIDE >A> AB TARO PHARM INDS LTD EQ 10MG BASE A 213063 001 Jul 01, 2020 Jun NEWA >A> AB EQ 25MG BASE A 213063 002 Jul 01, 2020 Jun NEWA >A> AB EQ 50MG BASE A 213063 003 Jul 01, 2020 Jun NEWA >A> AB EQ 75MG BASE A 213063 004 Jul 01, 2020 Jun NEWA >A> AB EQ 100MG BASE A 213063 005 Jul 01, 2020 Jun NEWA

DOXYCYCLINE HYCLATE TABLET;ORAL DOXYCYCLINE HYCLATE >A> AB ALEMBIC PHARMS LTD EQ 75MG BASE A 211744 001 Jun 30, 2020 Jun NEWA >A> AB EQ 150MG BASE A 211744 002 Jun 30, 2020 Jun NEWA

DROSPIRENONE; ETHINYL ESTRADIOL TABLET;ORAL-28 DROSPIRENONE AND ETHINYL ESTRADIOL >D> AB ACCORD HLTHCARE 3MG;0.03MG A 207245 001 Nov 22, 2016 Jun CAHN >A> AB NAARI PTE LTD 3MG;0.03MG A 207245 001 Nov 22, 2016 Jun CAHN

ERAVACYCLINE DIHYDROCHLORIDE POWDER;INTRAVENOUS XERAVA >A> +! TETRAPHASE PHARMS EQ 100MG BASE/VIAL N 211109 002 Jun 03, 2020 Jun NEWA

ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL ESTRADIOL AND NORETHINDRONE ACETATE >D> @ ACCORD HLTHCARE 1MG;0.5MG A 210233 001 Feb 28, 2018 Jun CAHN >A> @ NAARI PTE LTD 1MG;0.5MG A 210233 001 Feb 28, 2018 Jun CAHN

ETHACRYNATE SODIUM INJECTABLE;INJECTION ETHACRYNATE SODIUM >A> AP VPI PHARMS INC EQ 50MG BASE/VIAL A 208663 001 Jun 09, 2020 Jun NEWA

ETHINYL ESTRADIOL; LEVONORGESTREL TABLET, CHEWABLE;ORAL >D> LEVONORGESTREL AND ETHINYL ESTRADIOL >D> +! EXELTIS USA INC 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Jun CTNA >A> TYBLUME >A> +! EXELTIS USA INC 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Jun CTNA TABLET;ORAL-28 ORSYTHIA >D> AB1 VINTAGE PHARMS LLC 0.02MG;0.1MG A 077099 001 May 11, 2011 Jun DISC >A> @ 0.02MG;0.1MG A 077099 001 May 11, 2011 Jun DISC

ETHINYL ESTRADIOL; NORETHINDRONE TABLET, CHEWABLE;ORAL NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE >D> AB ACCORD HLTHCARE 0.035MG;0.4MG A 207066 001 Mar 29, 2017 Jun CAHN >A> AB NAARI PTE LTD 0.035MG;0.4MG A 207066 001 Mar 29, 2017 Jun CAHN TABLET;ORAL-28 NORETHINDRONE AND ETHINYL ESTRADIOL >D> AB ACCORD HLTHCARE 0.035MG;1MG A 206864 001 Apr 28, 2017 Jun CAHN >A> AB NAARI PTE LTD 0.035MG;1MG A 206864 001 Apr 28, 2017 Jun CAHN

Page 8 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE >D> AB MYLAN LABS LTD 0.02MG;1MG A 202742 001 Oct 30, 2014 Jun DISC >A> @ 0.02MG;1MG A 202742 001 Oct 30, 2014 Jun DISC TABLET;ORAL-21 GILDESS 1.5/30 >D> AB VINTAGE PHARMS LLC 0.03MG;1.5MG A 077075 002 Jul 24, 2012 Jun DISC >A> @ 0.03MG;1.5MG A 077075 002 Jul 24, 2012 Jun DISC TABLET;ORAL-28 GILDESS FE 1.5/30 >D> AB VINTAGE PHARMS LLC 0.03MG;1.5MG A 077075 001 Apr 28, 2005 Jun DISC >A> @ 0.03MG;1.5MG A 077075 001 Apr 28, 2005 Jun DISC

ETHINYL ESTRADIOL; NORGESTIMATE TABLET;ORAL-28 >D> TRI-PREVIFEM >D> AB VINTAGE PHARMS LLC 0.035MG,0.035MG,0.035MG;0.18MG, A 076335 001 Mar 26, 2004 Jun DISC 0.215MG,0.25MG >A> @ 0.035MG,0.035MG,0.035MG;0.18MG, A 076335 001 Mar 26, 2004 Jun DISC 0.215MG,0.25MG

EVEROLIMUS TABLET;ORAL EVEROLIMUS >A> AB HIKMA 2.5MG A 207486 001 Jun 08, 2020 Jun NEWA >A> AB 5MG A 207486 002 Jun 08, 2020 Jun NEWA >A> AB 7.5MG A 207486 003 Jun 08, 2020 Jun NEWA >A> AB MYLAN 2.5MG A 212936 001 Jun 08, 2020 Jun NEWA >A> AB 5MG A 212936 002 Jun 08, 2020 Jun NEWA >A> AB 7.5MG A 212936 003 Jun 08, 2020 Jun NEWA >A> AB 10MG A 212936 004 Jun 08, 2020 Jun NEWA >D> AB TEVA PHARMS USA 2.5MG A 210050 001 Dec 09, 2019 Jun DISC >A> @ 2.5MG A 210050 001 Dec 09, 2019 Jun DISC >A> AB 2.5MG A 210050 001 Dec 09, 2019 Jun CMFD >D> AB 5MG A 210050 002 Dec 09, 2019 Jun DISC >A> @ 5MG A 210050 002 Dec 09, 2019 Jun DISC >A> AB 5MG A 210050 002 Dec 09, 2019 Jun CMFD >D> AB 7.5MG A 210050 003 Dec 09, 2019 Jun DISC >A> AB 7.5MG A 210050 003 Dec 09, 2019 Jun CMFD >A> @ 7.5MG A 210050 003 Dec 09, 2019 Jun DISC >D> AB 10MG A 210050 004 Dec 09, 2019 Jun DISC >A> @ 10MG A 210050 004 Dec 09, 2019 Jun DISC

>A> FENFLURAMINE HYDROCHLORIDE >A> SOLUTION;ORAL >A> FINTEPLA >A> +! ZOGENIX INC EQ 2.2MG BASE/ML N 212102 001 Jun 25, 2020 Jun NEWA

FENOFIBRATE TABLET;ORAL FENOFIBRATE >A> AB MANKIND PHARMA 54MG A 213864 001 Jun 12, 2020 Jun NEWA >A> AB 160MG A 213864 002 Jun 12, 2020 Jun NEWA

FERRIC DERISOMALTOSE SOLUTION;INTRAVENOUS MONOFERRIC >D> +! PHARMACOSMOS AS 100MG/ML (100MG/ML) N 208171 001 Jan 16, 2020 Jun DISC >A> + @ 100MG/ML (100MG/ML) N 208171 001 Jan 16, 2020 Jun DISC >D> +! 500MG/5ML (100MG/ML) N 208171 002 Jan 16, 2020 Jun DISC >A> + @ 500MG/5ML (100MG/ML) N 208171 002 Jan 16, 2020 Jun DISC

FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL FINGOLIMOD HYDROCHLORIDE >D> AB BIOCON LTD EQ 0.5MG BASE A 207979 001 Dec 04, 2019 Jun DISC >A> @ EQ 0.5MG BASE A 207979 001 Dec 04, 2019 Jun DISC >A> AB GLENMARK PHARMS LTD EQ 0.5MG BASE A 207985 001 Jun 18, 2020 Jun NEWA >A> AB STRIDES PHARMA EQ 0.5MG BASE A 207971 001 Jun 29, 2020 Jun NEWA

Page 9 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FLUOXETINE HYDROCHLORIDE TABLET;ORAL FLUOXETINE HYDROCHLORIDE >A> AB AUROBINDO PHARMA LTD EQ 60MG BASE A 213265 001 Jun 10, 2020 Jun NEWA

FOLIC ACID TABLET;ORAL FOLIC ACID >D> AA VINTAGE 1MG A 040756 001 Jun 04, 2010 Jun DISC >A> @ 1MG A 040756 001 Jun 04, 2010 Jun DISC

FUROSEMIDE INJECTABLE;INJECTION FUROSEMIDE >A> AP GLAND PHARMA LTD 10MG/ML A 213902 001 Jul 01, 2020 Jun NEWA

GABAPENTIN CAPSULE;ORAL NEURONTIN >D> AB + PFIZER PHARMS 100MG N 020235 001 Dec 30, 1993 Jun CAHN >D> AB + 300MG N 020235 002 Dec 30, 1993 Jun CAHN >D> AB +! 400MG N 020235 003 Dec 30, 1993 Jun CAHN >A> AB + UPJOHN 100MG N 020235 001 Dec 30, 1993 Jun CAHN >A> AB + 300MG N 020235 002 Dec 30, 1993 Jun CAHN >A> AB +! 400MG N 020235 003 Dec 30, 1993 Jun CAHN SOLUTION;ORAL NEURONTIN >D> AA +! PARKE DAVIS 250MG/5ML N 021129 001 Mar 02, 2000 Jun CAHN >A> AA +! UPJOHN 250MG/5ML N 021129 001 Mar 02, 2000 Jun CAHN TABLET;ORAL NEURONTIN >D> AB + PFIZER PHARMS 600MG N 020882 001 Oct 09, 1998 Jun CAHN >D> AB +! 800MG N 020882 002 Oct 09, 1998 Jun CAHN >A> AB + UPJOHN 600MG N 020882 001 Oct 09, 1998 Jun CAHN >A> AB +! 800MG N 020882 002 Oct 09, 1998 Jun CAHN

GRANISETRON HYDROCHLORIDE INJECTABLE;INJECTION GRANISETRON HYDROCHLORIDE >A> AP YUNG SHIN PHARM EQ 1MG BASE/ML (EQ 1MG BASE/ML) A 202648 001 Jun 29, 2020 Jun NEWA >A> AP EQ 4MG BASE/4ML (EQ 1MG A 202648 002 Jun 29, 2020 Jun NEWA BASE/ML)

HALOBETASOL PROPIONATE LOTION;TOPICAL HALOBETASOL PROPIONATE >D> AB PERRIGO ISRAEL 0.05% A 211464 001 Jun 03, 2020 Jun DISC >A> @ 0.05% A 211464 001 Jun 03, 2020 Jun DISC ULTRAVATE >D> AB +! SUN PHARM INDUSTRIES 0.05% N 208183 001 Nov 06, 2015 Jun CTEC >A> +! 0.05% N 208183 001 Nov 06, 2015 Jun CTEC

HALOPERIDOL TABLET;ORAL HALOPERIDOL >D> AB APPCO 0.5MG A 211061 001 Jan 08, 2020 Jun CAHN >D> AB 1MG A 211061 002 Jan 08, 2020 Jun CAHN >D> AB 2MG A 211061 003 Jan 08, 2020 Jun CAHN >D> AB 5MG A 211061 004 Jan 08, 2020 Jun CAHN >D> AB 10MG A 211061 005 Jan 08, 2020 Jun CAHN >D> AB 20MG A 211061 006 Jan 08, 2020 Jun CAHN >A> AB UPSHER SMITH LABS 0.5MG A 211061 001 Jan 08, 2020 Jun CAHN >A> AB 1MG A 211061 002 Jan 08, 2020 Jun CAHN >A> AB 2MG A 211061 003 Jan 08, 2020 Jun CAHN >A> AB 5MG A 211061 004 Jan 08, 2020 Jun CAHN >A> AB 10MG A 211061 005 Jan 08, 2020 Jun CAHN >A> AB 20MG A 211061 006 Jan 08, 2020 Jun CAHN

Page 10 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HEPARIN SODIUM INJECTABLE;INJECTION HEPARIN SODIUM >D> +! PFIZER 10,000 UNITS/ML N 201370 003 Jul 21, 2011 Jun DISC >A> + @ 10,000 UNITS/ML N 201370 003 Jul 21, 2011 Jun DISC

HYDROCORTISONE ACETATE CREAM;TOPICAL HYDROCORTISONE ACETATE >D> @ FERNDALE LABS 2.5% A 040259 001 Jul 29, 1999 Jun CAHN >A> @ IMPERIUM 2.5% A 040259 001 Jul 29, 1999 Jun CAHN

ICATIBANT ACETATE INJECTABLE;SUBCUTANEOUS ICATIBANT ACETATE >A> AP FRESENIUS KABI USA EQ 30MG BASE/3ML (EQ 10MG A 208317 001 Jun 18, 2020 Jun NEWA BASE/ML)

INGENOL MEBUTATE GEL;TOPICAL >D> INGENOL MEBUTATE >D> AB PERRIGO UK FINCO 0.015% A 209018 001 Jan 07, 2019 Jun DISC >A> @ 0.015% A 209018 001 Jan 07, 2019 Jun DISC >D> AB 0.05% A 209019 001 Jan 09, 2019 Jun DISC >A> @ 0.05% A 209019 001 Jan 09, 2019 Jun DISC PICATO >D> AB +! LEO LABS 0.015% N 202833 001 Jan 23, 2012 Jun CTEC >A> +! 0.015% N 202833 001 Jan 23, 2012 Jun CTEC >D> AB +! 0.05% N 202833 002 Jan 23, 2012 Jun CTEC >A> +! 0.05% N 202833 002 Jan 23, 2012 Jun CTEC

ISOTRETINOIN CAPSULE;ORAL ABSORICA LD >D> + SUN PHARM 20MG N 211913 003 Nov 05, 2019 Jun DISC >A> + @ 20MG N 211913 003 Nov 05, 2019 Jun DISC >D> + 28MG N 211913 005 Nov 05, 2019 Jun DISC >A> + @ 28MG N 211913 005 Nov 05, 2019 Jun DISC

IVACAFTOR TABLET;ORAL KALYDECO >D> + VERTEX PHARMS 75MG N 203188 002 May 20, 2019 Jun DISC >A> + @ 75MG N 203188 002 May 20, 2019 Jun DISC

LATANOPROST SOLUTION/DROPS;OPHTHALMIC XALATAN >D> AT +! PHARMACIA AND UPJOHN 0.005% N 020597 001 Jun 05, 1996 Jun CAHN >A> AT +! UPJOHN 0.005% N 020597 001 Jun 05, 1996 Jun CAHN

LEVETIRACETAM SOLUTION;ORAL LEVETIRACETAM >D> @ ACI HEALTHCARE LTD 100MG/ML A 078582 001 Jan 15, 2009 Jun CMFD >A> AA 100MG/ML A 078582 001 Jan 15, 2009 Jun CMFD TABLET, EXTENDED RELEASE;ORAL LEVETIRACETAM >A> AB OVERSEAS 750MG A 212688 001 Jun 11, 2020 Jun NEWA TABLET;ORAL LEVETIRACETAM >D> AB VINTAGE PHARMS 250MG A 091491 001 Dec 14, 2010 Jun CAHN >D> AB 500MG A 091491 002 Dec 14, 2010 Jun CAHN >D> AB 750MG A 091491 003 Dec 14, 2010 Jun CAHN >D> AB 1GM A 091491 004 Dec 14, 2010 Jun CAHN >A> AB ZHEJIANG JINGXIN 250MG A 091491 001 Dec 14, 2010 Jun CAHN >A> AB 500MG A 091491 002 Dec 14, 2010 Jun CAHN >A> AB 750MG A 091491 003 Dec 14, 2010 Jun CAHN >A> AB 1GM A 091491 004 Dec 14, 2010 Jun CAHN

Page 11 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LEVORPHANOL TARTRATE TABLET;ORAL LEVORPHANOL TARTRATE >A> AB NOVITIUM PHARMA 2MG A 213479 001 Jul 01, 2020 Jun NEWA

LIDOCAINE HYDROCHLORIDE SOLUTION;TOPICAL LIDOCAINE HYDROCHLORIDE >D> @ WOCKHARDT BIO AG 4% A 087881 001 Nov 18, 1982 Jun CMFD >A> AT 4% A 087881 001 Nov 18, 1982 Jun CMFD

LOFEXIDINE HYDROCHLORIDE TABLET;ORAL LUCEMYRA >D> +! US WORLDMEDS LLC EQ 0.18MG BASE N 209229 001 May 16, 2018 Jun CAHN >A> +! USWM EQ 0.18MG BASE N 209229 001 May 16, 2018 Jun CAHN

>A> LURBINECTEDIN >A> POWDER;INTRAVENOUS >A> ZEPZELCA >A> +! JAZZ 4MG/VIAL N 213702 001 Jun 15, 2020 Jun NEWA

MECLIZINE HYDROCHLORIDE TABLET;ORAL MECLIZINE HYDROCHLORIDE >D> INDICUS PHARMA 50MG A 205136 003 Feb 22, 2019 Jun CTEC >A> AA 50MG A 205136 003 Feb 22, 2019 Jun CTEC >A> AA ZYDUS 12.5MG A 213957 001 Jun 23, 2020 Jun NEWA >A> AA 25MG A 213957 002 Jun 23, 2020 Jun NEWA

MELPHALAN HYDROCHLORIDE INJECTABLE;INJECTION MELPHALAN HYDROCHLORIDE >D> @ US WORLDMEDS LLC EQ 50MG BASE/VIAL A 207032 001 May 03, 2019 Jun CAHN >A> @ USWM EQ 50MG BASE/VIAL A 207032 001 May 03, 2019 Jun CAHN

METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL METFORMIN HYDROCHLORIDE >D> @ YICHANG HUMANWELL 500MG A 211052 001 Sep 24, 2018 Jun CMFD >A> AB1 500MG A 211052 001 Sep 24, 2018 Jun CMFD >D> @ 750MG A 211052 002 Sep 24, 2018 Jun CMFD >A> AB 750MG A 211052 002 Sep 24, 2018 Jun CMFD

METHADONE HYDROCHLORIDE TABLET;ORAL DOLOPHINE HYDROCHLORIDE >D> AA +! HIKMA 5MG N 006134 002 Aug 13, 1947 Jun DISC >A> + @ 5MG N 006134 002 Aug 13, 1947 Jun DISC >D> AA +! 10MG N 006134 010 Aug 13, 1947 Jun DISC >A> + @ 10MG N 006134 010 Aug 13, 1947 Jun DISC METHADONE HYDROCHLORIDE >D> AA SPECGX LLC 5MG A 040517 001 Apr 27, 2004 Jun CHRS >A> AA ! 5MG A 040517 001 Apr 27, 2004 Jun CHRS >D> AA 10MG A 040517 002 Apr 27, 2004 Jun CHRS >A> AA ! 10MG A 040517 002 Apr 27, 2004 Jun CHRS

METHYLENE BLUE SOLUTION;INTRAVENOUS PROVAYBLUE >A> +! PROVEPHARM SAS 10MG/2ML (5MG/ML) N 204630 002 Jul 18, 2019 Jun NEWA

METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL COTEMPLA XR-ODT >D> + NEOS THERAPS INC 8.6MG N 205489 001 Jun 19, 2017 Jun CFTG >A> AB + 8.6MG N 205489 001 Jun 19, 2017 Jun CFTG >D> + 17.3MG N 205489 002 Jun 19, 2017 Jun CFTG >A> AB + 17.3MG N 205489 002 Jun 19, 2017 Jun CFTG >D> + 25.9MG N 205489 003 Jun 19, 2017 Jun CHRS >A> AB +! 25.9MG N 205489 003 Jun 19, 2017 Jun CFTG

Page 12 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL COTEMPLA XR-ODT >A> +! 25.9MG N 205489 003 Jun 19, 2017 Jun CHRS >A> METHYLPHENIDATE >A> AB ACTAVIS ELIZABETH 8.6MG A 210924 001 Jun 19, 2020 Jun NFTG >A> AB 17.3MG A 210924 002 Jun 19, 2020 Jun NFTG >A> AB 25.9MG A 210924 003 Jun 19, 2020 Jun NFTG

METHYLPHENIDATE HYDROCHLORIDE SOLUTION;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AA QUAGEN 5MG/5ML A 213567 001 Jun 04, 2020 Jun NEWA >A> AA 10MG/5ML A 213567 002 Jun 04, 2020 Jun NEWA

METOCLOPRAMIDE HYDROCHLORIDE >A> SPRAY, METERED;NASAL >A> GIMOTI >A> +! EVOKE PHARMA INC EQ 15MG BASE/SPRAY N 209388 001 Jun 19, 2020 Jun NEWA

METRONIDAZOLE INJECTABLE;INJECTION METRONIDAZOLE IN PLASTIC CONTAINER >D> AP MYLAN LABS LTD 500MG/100ML A 205531 001 May 09, 2017 Jun DISC >A> @ 500MG/100ML A 205531 001 May 09, 2017 Jun DISC

MEXILETINE HYDROCHLORIDE CAPSULE;ORAL MEXILETINE HYDROCHLORIDE >D> @ ANI PHARMS INC 150MG A 074450 001 May 16, 1996 Jun CMFD >A> AB 150MG A 074450 001 May 16, 1996 Jun CMFD >D> @ 200MG A 074450 002 May 16, 1996 Jun CMFD >A> AB 200MG A 074450 002 May 16, 1996 Jun CMFD >D> @ 250MG A 074450 003 May 16, 1996 Jun CMFD >A> AB 250MG A 074450 003 May 16, 1996 Jun CMFD >D> TEVA 150MG A 074377 001 May 16, 1995 Jun CTEC >A> AB 150MG A 074377 001 May 16, 1995 Jun CTEC >D> 200MG A 074377 002 May 16, 1995 Jun CTEC >A> AB 200MG A 074377 002 May 16, 1995 Jun CTEC >D> ! 250MG A 074377 003 May 16, 1995 Jun CTEC >A> AB ! 250MG A 074377 003 May 16, 1995 Jun CTEC

MORPHINE SULFATE INJECTABLE;INJECTION MORPHINE SULFATE >D> +! MERIDIAN MEDCL TECHN 15MG/ML N 019999 001 Jul 12, 1990 Jun CDFR >A> SOLUTION;INTRAMUSCULAR >A> MORPHINE SULFATE >A> +! MERIDIAN MEDCL TECHN 15MG/ML N 019999 001 Jul 12, 1990 Jun CDFR MORPHINE SULFATE (AUTOINJECTOR) >A> +! MERIDIAN MEDCL TECHN 10MG/0.7ML (10MG/0.7ML) N 019999 001 Jul 12, 1990 Jun CPOT >A> +! 15MG/ML N 019999 001 Jul 12, 1990 Jun CTNA

MYCOPHENOLATE MOFETIL CAPSULE;ORAL MYCOPHENOLATE MOFETIL >D> AB VINTAGE PHARMS LLC 250MG A 090111 001 Dec 22, 2009 Jun DISC >A> @ 250MG A 090111 001 Dec 22, 2009 Jun DISC

NADOLOL TABLET;ORAL CORGARD >D> AB + US WORLDMEDS LLC 20MG N 018063 005 Oct 28, 1986 Jun CAHN >D> AB + 40MG N 018063 001 Dec 10, 1979 Jun CAHN >D> AB +! 80MG N 018063 002 Dec 10, 1979 Jun CAHN >D> @ 120MG N 018063 003 Dec 10, 1979 Jun CAHN >D> @ 160MG N 018063 004 Dec 10, 1979 Jun CAHN >A> AB + USWM 20MG N 018063 005 Oct 28, 1986 Jun CAHN >A> AB + 40MG N 018063 001 Dec 10, 1979 Jun CAHN >A> AB +! 80MG N 018063 002 Dec 10, 1979 Jun CAHN

Page 13 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

NADOLOL TABLET;ORAL CORGARD >A> @ 120MG N 018063 003 Dec 10, 1979 Jun CAHN >A> @ 160MG N 018063 004 Dec 10, 1979 Jun CAHN

NORETHINDRONE TABLET;ORAL-28 NORETHINDRONE >D> AB1 ACCORD HLTHCARE 0.35MG A 206807 001 Dec 13, 2016 Jun CAHN >A> AB1 NAARI PTE LTD 0.35MG A 206807 001 Dec 13, 2016 Jun CAHN

NUSINERSEN SODIUM SOLUTION;INTRATHECAL SPINRAZA >D> +! BIOGEN IDEC 12MG/5ML (2.4MG/ML) N 209531 001 Dec 23, 2016 Jun CPOT >A> +! EQ 12MG BASE/5ML (EQ 2.4MG N 209531 001 Dec 23, 2016 Jun CPOT BASE/ML)

NYSTATIN; TRIAMCINOLONE ACETONIDE OINTMENT;TOPICAL NYSTATIN AND TRIAMCINOLONE ACETONIDE >A> AT CADILA 100,000 UNITS/GM;0.1% A 207764 001 Nov 08, 2018 Jun CAHN >D> AT ZYDUS PHARMS 100,000 UNITS/GM;0.1% A 207764 001 Nov 08, 2018 Jun CAHN

OCTREOTIDE ACETATE >A> CAPSULE, DELAYED RELEASE;ORAL >A> MYCAPSSA >A> +! CHIASMA EQ 20MG BASE N 208232 001 Jun 26, 2020 Jun NEWA

OMEGA-3-ACID ETHYL ESTERS CAPSULE;ORAL OMEGA-3-ACID ETHYL ESTERS >A> AB PURACAP PHARM LLC 1GM CONTAINS AT LEAST 900MG OF A 210093 001 Jun 15, 2020 Jun NEWA THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS

ONDANSETRON HYDROCHLORIDE INJECTABLE;INJECTION ONDANSETRON HYDROCHLORIDE >D> AP GLAND PHARMA LTD EQ 2MG BASE/ML A 090648 001 Jun 15, 2012 Jun CHRS >A> AP ! EQ 2MG BASE/ML A 090648 001 Jun 15, 2012 Jun CHRS

PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL >A> PANTOPRAZOLE SODIUM >A> AB SUN PHARM EQ 40MG BASE A 213725 001 Jun 30, 2020 Jun NFTG PROTONIX >D> +! WYETH PHARMS EQ 40MG BASE N 022020 001 Nov 14, 2007 Jun CFTG >A> AB +! EQ 40MG BASE N 022020 001 Nov 14, 2007 Jun CFTG

PHENOXYBENZAMINE HYDROCHLORIDE CAPSULE;ORAL DIBENZYLINE >D> + @ CONCORDIA 10MG N 008708 001 Jan 26, 1953 Jun CMFD >A> AB + 10MG N 008708 001 Jan 26, 1953 Jun CMFD

PHENYLEPHRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS PHENYLEPHRINE HYDROCHLORIDE >A> AP1 ACCORD HLTHCARE 10MG/ML (10MG/ML) A 213237 001 Jul 01, 2020 Jun NEWA >A> AP1 50MG/5ML (10MG/ML) A 213237 002 Jul 01, 2020 Jun NEWA >A> AP1 100MG/10ML (10MG/ML) A 213237 003 Jul 01, 2020 Jun NEWA >A> AP1 CAPLIN 10MG/ML (10MG/ML) A 213318 001 Jun 11, 2020 Jun NEWA >A> AP1 50MG/5ML (10MG/ML) A 213318 002 Jun 11, 2020 Jun NEWA >A> AP1 100MG/10ML (10MG/ML) A 213318 003 Jun 11, 2020 Jun NEWA >A> AP1 GLAND PHARMA LTD 50MG/5ML (10MG/ML) A 211920 001 Jun 05, 2020 Jun NEWA >A> AP1 100MG/10ML (10MG/ML) A 211920 002 Jun 05, 2020 Jun NEWA >D> AP1 RICONPHARMA LLC 10MG/ML (10MG/ML) A 209967 001 Jan 16, 2020 Jun CAHN >D> AP1 50MG/5ML (10MG/ML) A 209967 002 Jan 16, 2020 Jun CAHN >D> AP1 100MG/10ML (10MG/ML) A 209967 003 Jan 16, 2020 Jun CAHN

Page 14 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PHENYLEPHRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS PHENYLEPHRINE HYDROCHLORIDE >A> AP1 SAGENT PHARMS INC 10MG/ML (10MG/ML) A 209967 001 Jan 16, 2020 Jun CAHN >A> AP1 50MG/5ML (10MG/ML) A 209967 002 Jan 16, 2020 Jun CAHN >A> AP1 100MG/10ML (10MG/ML) A 209967 003 Jan 16, 2020 Jun CAHN

PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE >A> AA ! PHARM ASSOC 5MG/5ML;6.25MG/5ML A 040654 001 Dec 07, 2006 Jun CAHN >D> AA ! VINTAGE 5MG/5ML;6.25MG/5ML A 040654 001 Dec 07, 2006 Jun CAHN

POTASSIUM CITRATE TABLET, EXTENDED RELEASE;ORAL POTASSIUM CITRATE >A> AB BIONPHARMA INC 10MEQ A 212799 001 Jun 29, 2020 Jun NEWA >A> AB 15MEQ A 212799 002 Jun 29, 2020 Jun NEWA

PRALIDOXIME CHLORIDE INJECTABLE;INJECTION PRALIDOXIME CHLORIDE >D> +! MERIDIAN MEDCL TECHN 300MG/ML N 018986 001 Apr 26, 1983 Jun CTNA >A> PRALIDOXIME CHLORIDE (AUTOINJECTOR) >A> +! MERIDIAN MEDCL TECHN 300MG/ML N 018986 001 Apr 26, 1983 Jun CTNA >A> SOLUTION;INTRAMUSCULAR >A> PRALIDOXIME CHLORIDE (AUTOINJECTOR) >A> +! MERIDIAN MEDCL TECHN 300MG/ML N 018986 001 Apr 26, 1983 Jun CDFR >A> +! 600MG/2ML (300MG/ML) N 018986 001 Apr 26, 1983 Jun CPOT

PRAMIPEXOLE DIHYDROCHLORIDE TABLET;ORAL PRAMIPEXOLE DIHYDROCHLORIDE >D> AB MACLEODS PHARMS LTD 0.125MG A 202164 001 Sep 20, 2012 Jun DISC >A> @ 0.125MG A 202164 001 Sep 20, 2012 Jun DISC >D> AB 0.25MG A 202164 002 Sep 20, 2012 Jun DISC >A> @ 0.25MG A 202164 002 Sep 20, 2012 Jun DISC >D> AB 0.5MG A 202164 003 Sep 20, 2012 Jun DISC >A> @ 0.5MG A 202164 003 Sep 20, 2012 Jun DISC >D> AB 1MG A 202164 004 Sep 20, 2012 Jun DISC >A> @ 1MG A 202164 004 Sep 20, 2012 Jun DISC >D> AB 1.5MG A 202164 005 Sep 20, 2012 Jun DISC >A> @ 1.5MG A 202164 005 Sep 20, 2012 Jun DISC

PRASTERONE INSERT;VAGINAL INTRAROSA >D> +! AMAG PHARMS INC 6.5MG N 208470 001 Nov 16, 2016 Jun CAHN >A> +! MILLICENT 6.5MG N 208470 001 Nov 16, 2016 Jun CAHN

PREDNISOLONE SODIUM PHOSPHATE SOLUTION;ORAL PREDNISOLONE SODIUM PHOSPHATE >D> AA VINTAGE EQ 15MG BASE/5ML A 079010 001 May 26, 2009 Jun DISC >A> @ EQ 15MG BASE/5ML A 079010 001 May 26, 2009 Jun DISC

PREDNISONE TABLET;ORAL PREDNISONE >A> AB AMNEAL 1MG A 213385 001 Jun 16, 2020 Jun NEWA >A> AB 5MG A 213385 002 Jun 16, 2020 Jun NEWA >A> AB 10MG A 213386 001 Jun 24, 2020 Jun NEWA >A> AB 20MG A 213386 002 Jun 24, 2020 Jun NEWA

PREGABALIN CAPSULE;ORAL LYRICA >D> AB + PF PRISM CV 25MG N 021446 001 Dec 30, 2004 Jun CAHN >D> AB + 50MG N 021446 002 Dec 30, 2004 Jun CAHN >D> AB + 75MG N 021446 003 Dec 30, 2004 Jun CAHN >D> AB + 100MG N 021446 004 Dec 30, 2004 Jun CAHN

Page 15 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PREGABALIN CAPSULE;ORAL LYRICA >D> AB + 150MG N 021446 005 Dec 30, 2004 Jun CAHN >D> AB + 200MG N 021446 006 Dec 30, 2004 Jun CAHN >D> AB + 225MG N 021446 007 Dec 30, 2004 Jun CAHN >D> AB +! 300MG N 021446 008 Dec 30, 2004 Jun CAHN >A> AB + PFIZER 25MG N 021446 001 Dec 30, 2004 Jun CAHN >A> AB + 50MG N 021446 002 Dec 30, 2004 Jun CAHN >A> AB + 75MG N 021446 003 Dec 30, 2004 Jun CAHN >A> AB + 100MG N 021446 004 Dec 30, 2004 Jun CAHN >A> AB + 150MG N 021446 005 Dec 30, 2004 Jun CAHN >A> AB + 200MG N 021446 006 Dec 30, 2004 Jun CAHN >A> AB + 225MG N 021446 007 Dec 30, 2004 Jun CAHN >A> AB +! 300MG N 021446 008 Dec 30, 2004 Jun CAHN SOLUTION;ORAL LYRICA >D> AA +! PF PRISM CV 20MG/ML N 022488 001 Jan 04, 2010 Jun CAHN >A> AA +! PFIZER 20MG/ML N 022488 001 Jan 04, 2010 Jun CAHN TABLET, EXTENDED RELEASE;ORAL LYRICA CR >D> + PF PRISM CV 82.5MG N 209501 001 Oct 11, 2017 Jun CAHN >D> + 165MG N 209501 002 Oct 11, 2017 Jun CAHN >D> +! 330MG N 209501 003 Oct 11, 2017 Jun CAHN >A> + PFIZER 82.5MG N 209501 001 Oct 11, 2017 Jun CAHN >A> + 165MG N 209501 002 Oct 11, 2017 Jun CAHN >A> +! 330MG N 209501 003 Oct 11, 2017 Jun CAHN

PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE HYDROCHLORIDE >A> @ PHARM ASSOC 6.25MG/5ML A 040643 001 Apr 26, 2006 Jun CAHN >D> AA VINTAGE 6.25MG/5ML A 040643 001 Apr 26, 2006 Jun DISC >A> @ 6.25MG/5ML A 040643 001 Apr 26, 2006 Jun DISC

PROPAFENONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL PROPAFENONE HYDROCHLORIDE >A> AB TWI PHARMS 225MG A 212928 001 Jun 18, 2020 Jun NEWA >A> AB 325MG A 212928 002 Jun 18, 2020 Jun NEWA >A> AB 425MG A 212928 003 Jun 18, 2020 Jun NEWA >A> AB UPSHER SMITH LABS 225MG A 212744 001 Jun 25, 2020 Jun NEWA >A> AB 325MG A 212744 002 Jun 25, 2020 Jun NEWA >A> AB 425MG A 212744 003 Jun 25, 2020 Jun NEWA

RANITIDINE HYDROCHLORIDE CAPSULE;ORAL RANITIDINE HYDROCHLORIDE >D> AB AJANTA PHARMA LTD EQ 150MG BASE A 209859 001 Sep 27, 2018 Jun DISC >A> @ EQ 150MG BASE A 209859 001 Sep 27, 2018 Jun DISC >D> AB EQ 300MG BASE A 209859 002 Sep 27, 2018 Jun DISC >A> @ EQ 300MG BASE A 209859 002 Sep 27, 2018 Jun DISC

RISPERIDONE TABLET;ORAL RISPERIDONE >D> AB MYLAN 0.25MG A 076288 001 Sep 15, 2008 Jun DISC >A> @ 0.25MG A 076288 001 Sep 15, 2008 Jun DISC

ROFLUMILAST TABLET;ORAL ROFLUMILAST >D> AB MICRO LABS 500MCG A 208180 001 Mar 22, 2019 Jun DISC >A> @ 500MCG A 208180 001 Mar 22, 2019 Jun DISC

Page 16 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ROSUVASTATIN CALCIUM TABLET;ORAL ROSUVASTATIN CALCIUM >D> AB APOTEX INC 5MG A 079145 001 Jul 19, 2016 Jun DISC >A> @ 5MG A 079145 001 Jul 19, 2016 Jun DISC >D> AB 10MG A 079145 002 Jul 19, 2016 Jun DISC >A> @ 10MG A 079145 002 Jul 19, 2016 Jun DISC >D> AB 20MG A 079145 003 Jul 19, 2016 Jun DISC >A> @ 20MG A 079145 003 Jul 19, 2016 Jun DISC >D> AB 40MG A 079145 004 Jul 19, 2016 Jun DISC >A> @ 40MG A 079145 004 Jul 19, 2016 Jun DISC

SERTRALINE HYDROCHLORIDE CONCENTRATE;ORAL ZOLOFT >D> AA +! PFIZER EQ 20MG BASE/ML N 020990 001 Dec 07, 1999 Jun CAHN >A> AA +! UPJOHN EQ 20MG BASE/ML N 020990 001 Dec 07, 1999 Jun CAHN TABLET;ORAL ZOLOFT >D> AB + PFIZER EQ 25MG BASE N 019839 005 Mar 06, 1996 Jun CAHN >D> AB + EQ 50MG BASE N 019839 001 Dec 30, 1991 Jun CAHN >D> AB +! EQ 100MG BASE N 019839 002 Dec 30, 1991 Jun CAHN >D> + @ EQ 150MG BASE N 019839 003 Dec 30, 1991 Jun CAHN >D> + @ EQ 200MG BASE N 019839 004 Dec 30, 1991 Jun CAHN >A> AB + UPJOHN EQ 25MG BASE N 019839 005 Mar 06, 1996 Jun CAHN >A> AB + EQ 50MG BASE N 019839 001 Dec 30, 1991 Jun CAHN >A> AB +! EQ 100MG BASE N 019839 002 Dec 30, 1991 Jun CAHN >A> + @ EQ 150MG BASE N 019839 003 Dec 30, 1991 Jun CAHN >A> + @ EQ 200MG BASE N 019839 004 Dec 30, 1991 Jun CAHN

SILDENAFIL CITRATE FOR SUSPENSION;ORAL REVATIO >D> AB +! PFIZER EQ 10MG BASE/ML N 203109 001 Aug 30, 2012 Jun CAHN >A> AB +! UPJOHN EQ 10MG BASE/ML N 203109 001 Aug 30, 2012 Jun CAHN SOLUTION;INTRAVENOUS REVATIO >D> AP +! PFIZER EQ 10MG BASE/12.5ML (EQ 0.8MG N 022473 001 Nov 18, 2009 Jun CAHN BASE/ML) >A> AP +! UPJOHN EQ 10MG BASE/12.5ML (EQ 0.8MG N 022473 001 Nov 18, 2009 Jun CAHN BASE/ML) TABLET;ORAL REVATIO >D> AB +! PFIZER EQ 20MG BASE N 021845 001 Jun 03, 2005 Jun CAHN >A> AB +! UPJOHN EQ 20MG BASE N 021845 001 Jun 03, 2005 Jun CAHN SILDENAFIL CITRATE >A> AB REYOUNG EQ 25MG BASE A 208494 001 Jun 12, 2020 Jun NEWA >A> AB EQ 50MG BASE A 208494 002 Jun 12, 2020 Jun NEWA >A> AB EQ 100MG BASE A 208494 003 Jun 12, 2020 Jun NEWA >A> AB SUNSHINE LAKE EQ 25MG BASE A 213032 001 Jun 11, 2020 Jun NEWA >A> AB EQ 50MG BASE A 213032 002 Jun 11, 2020 Jun NEWA >A> AB EQ 100MG BASE A 213032 003 Jun 11, 2020 Jun NEWA VIAGRA >D> AB + PFIZER INC EQ 25MG BASE N 020895 001 Mar 27, 1998 Jun CAHN >D> AB + EQ 50MG BASE N 020895 002 Mar 27, 1998 Jun CAHN >D> AB +! EQ 100MG BASE N 020895 003 Mar 27, 1998 Jun CAHN >A> AB + UPJOHN EQ 25MG BASE N 020895 001 Mar 27, 1998 Jun CAHN >A> AB + EQ 50MG BASE N 020895 002 Mar 27, 1998 Jun CAHN >A> AB +! EQ 100MG BASE N 020895 003 Mar 27, 1998 Jun CAHN

SODIUM BENZOATE; SODIUM PHENYLACETATE SOLUTION;INTRAVENOUS AMMONUL >A> AP +! BAUSCH 10%;10% (5GM/50ML;5GM/50ML) N 020645 001 Feb 17, 2005 Jun CAHN >D> AP +! MEDICIS 10%;10% (5GM/50ML;5GM/50ML) N 020645 001 Feb 17, 2005 Jun CAHN

Page 17 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>D> SODIUM LACTATE >D> INJECTABLE;INJECTION >D> SODIUM LACTATE IN PLASTIC CONTAINER >D> +! HOSPIRA 5MEQ/ML N 018947 001 Sep 05, 1984 Jun DISC >A> + @ 5MEQ/ML N 018947 001 Sep 05, 1984 Jun DISC

SUCCINYLCHOLINE CHLORIDE INJECTABLE;INJECTION SUCCINYLCHOLINE CHLORIDE >A> AP AMPHASTAR PHARMS INC 20MG/ML A 213432 001 Jun 08, 2020 Jun NEWA >A> AP GLAND PHARMA LTD 20MG/ML A 214246 001 Jun 16, 2020 Jun NEWA >A> AP HIKMA 20MG/ML A 213229 001 Jun 12, 2020 Jun NEWA

TEMOZOLOMIDE CAPSULE;ORAL TEMOZOLOMIDE >A> AB CHARTWELL 5MG A 206413 001 Apr 12, 2016 Jun CAHN >A> AB 20MG A 206413 002 Apr 12, 2016 Jun CAHN >A> AB 100MG A 206413 003 Apr 12, 2016 Jun CAHN >A> AB 140MG A 206413 004 Apr 12, 2016 Jun CAHN >A> AB 180MG A 206413 005 Apr 12, 2016 Jun CAHN >A> AB 250MG A 206413 006 Apr 12, 2016 Jun CAHN >D> AB IDT AUSTRALIA LTD 5MG A 206413 001 Apr 12, 2016 Jun CAHN >D> AB 20MG A 206413 002 Apr 12, 2016 Jun CAHN >D> AB 100MG A 206413 003 Apr 12, 2016 Jun CAHN >D> AB 140MG A 206413 004 Apr 12, 2016 Jun CAHN >D> AB 180MG A 206413 005 Apr 12, 2016 Jun CAHN >D> AB 250MG A 206413 006 Apr 12, 2016 Jun CAHN

TERBUTALINE SULFATE TABLET;ORAL TERBUTALINE SULFATE >A> AB TWI PHARMS 2.5MG A 211832 001 Jun 19, 2020 Jun NEWA >A> AB 5MG A 211832 002 Jun 19, 2020 Jun NEWA

TERIFLUNOMIDE TABLET;ORAL TERIFLUNOMIDE >A> AB IMPAX 14MG A 209677 001 Jun 17, 2020 Jun NEWA

THEOPHYLLINE TABLET, EXTENDED RELEASE;ORAL THEOPHYLLINE >D> AB ALEMBIC PHARMS LTD 300MG A 090430 001 Oct 27, 2010 Jun CTEC >A> 300MG A 090430 001 Oct 27, 2010 Jun CTEC >D> AB HERITAGE PHARMA 300MG A 089763 001 Apr 30, 1990 Jun DISC >A> @ 300MG A 089763 001 Apr 30, 1990 Jun DISC

TOLTERODINE TARTRATE TABLET;ORAL DETROL >D> AB + PHARMACIA AND UPJOHN 1MG N 020771 001 Mar 25, 1998 Jun CAHN >D> AB +! 2MG N 020771 002 Mar 25, 1998 Jun CAHN >A> AB + UPJOHN 1MG N 020771 001 Mar 25, 1998 Jun CAHN >A> AB +! 2MG N 020771 002 Mar 25, 1998 Jun CAHN

TRIAMCINOLONE ACETONIDE LOTION;TOPICAL TRIAMCINOLONE ACETONIDE >A> AT QUAGEN 0.025% A 213559 001 Jul 01, 2020 Jun NEWA >A> AT 0.1% A 213559 002 Jul 01, 2020 Jun NEWA

TROMETHAMINE INJECTABLE;INJECTION THAM >D> + @ HOSPIRA 3.6GM/100ML N 013025 002 Feb 08, 1971 Jun CMFD SOLUTION;INJECTION THAM >A> +! HOSPIRA 18GM/500ML (3.6GM/100ML) N 013025 002 Feb 08, 1971 Jun CMFD

Page 18 of 20 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VANCOMYCIN HYDROCHLORIDE FOR SOLUTION;ORAL FIRVANQ KIT >A> +! AZURITY EQ 25MG BASE/ML N 208910 001 Jan 26, 2018 Jun CAHN >A> +! EQ 50MG BASE/ML N 208910 002 Jan 26, 2018 Jun CAHN >D> +! RXMTM THERAPS LLC EQ 25MG BASE/ML N 208910 001 Jan 26, 2018 Jun CAHN >D> +! EQ 50MG BASE/ML N 208910 002 Jan 26, 2018 Jun CAHN INJECTABLE;INJECTION VANCOMYCIN HYDROCHLORIDE >D> @ HAINAN POLY PHARM EQ 500MG BASE/VIAL A 212332 001 Jun 12, 2019 Jun CMFD >A> AP EQ 500MG BASE/VIAL A 212332 001 Jun 12, 2019 Jun CMFD >D> @ EQ 1GM BASE/VIAL A 212332 002 Jun 12, 2019 Jun CMFD >A> AP EQ 1GM BASE/VIAL A 212332 002 Jun 12, 2019 Jun CMFD

VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EFFEXOR XR >A> AB + UPJOHN EQ 37.5MG BASE N 020699 001 Oct 20, 1997 Jun CAHN >A> AB + EQ 75MG BASE N 020699 002 Oct 20, 1997 Jun CAHN >A> @ EQ 100MG BASE N 020699 003 Oct 20, 1997 Jun CAHN >A> AB +! EQ 150MG BASE N 020699 004 Oct 20, 1997 Jun CAHN >D> AB + WYETH PHARMS EQ 37.5MG BASE N 020699 001 Oct 20, 1997 Jun CAHN >D> AB + EQ 75MG BASE N 020699 002 Oct 20, 1997 Jun CAHN >D> @ EQ 100MG BASE N 020699 003 Oct 20, 1997 Jun CAHN >D> AB +! EQ 150MG BASE N 020699 004 Oct 20, 1997 Jun CAHN

ZIPRASIDONE HYDROCHLORIDE CAPSULE;ORAL GEODON >D> AB +! PFIZER EQ 20MG BASE N 020825 001 Feb 05, 2001 Jun CAHN >D> AB + EQ 40MG BASE N 020825 002 Feb 05, 2001 Jun CAHN >D> AB + EQ 60MG BASE N 020825 003 Feb 05, 2001 Jun CAHN >D> AB + EQ 80MG BASE N 020825 004 Feb 05, 2001 Jun CAHN >A> AB +! UPJOHN EQ 20MG BASE N 020825 001 Feb 05, 2001 Jun CAHN >A> AB + EQ 40MG BASE N 020825 002 Feb 05, 2001 Jun CAHN >A> AB + EQ 60MG BASE N 020825 003 Feb 05, 2001 Jun CAHN >A> AB + EQ 80MG BASE N 020825 004 Feb 05, 2001 Jun CAHN

ZIPRASIDONE MESYLATE INJECTABLE;INTRAMUSCULAR GEODON >D> AP +! PFIZER EQ 20MG BASE/ML N 020919 001 Jun 21, 2002 Jun CAHN >A> AP +! UPJOHN EQ 20MG BASE/ML N 020919 001 Jun 21, 2002 Jun CAHN

ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL ZOLPIDEM TARTRATE >A> AB CENTAUR PHARMS PVT 6.25MG A 213592 001 Jun 04, 2020 Jun NEWA >A> AB 12.5MG A 213592 002 Jun 04, 2020 Jun NEWA TABLET;ORAL ZOLPIDEM TARTRATE >D> AB VINTAGE 5MG A 078616 001 Nov 21, 2008 Jun DISC >A> @ 5MG A 078616 001 Nov 21, 2008 Jun DISC >D> AB 10MG A 078616 002 Nov 21, 2008 Jun DISC >A> @ 10MG A 078616 002 Nov 21, 2008 Jun DISC

Page 19 of 20 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

ESOMEPRAZOLE MAGNESIUM TABLET, DELAYED RELEASE;ORAL ESOMEPRAZOLE MAGNESIUM >A> MYLAN EQ 20MG BASE A 212088 001 Jun 25, 2020 Jun NEWA

IBUPROFEN TABLET;ORAL IBUPROFEN >D> ULTRATAB LABS INC 200MG A 209076 001 Jan 06, 2020 Jun DISC >A> @ 200MG A 209076 001 Jan 06, 2020 Jun DISC

LEVONORGESTREL TABLET;ORAL LEVONORGESTREL >D> @ ACCORD HLTHCARE 1.5MG A 207660 001 May 02, 2019 Jun CAHN >A> @ NAARI PTE LTD 1.5MG A 207660 001 May 02, 2019 Jun CAHN

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC OLOPATADINE HYDROCHLORIDE >A> MICRO LABS LTD INDIA EQ 0.2% BASE A 204620 001 Jun 16, 2020 Jun NEWA

CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 20 of 20